Botanix Pharmaceuticals Says US Payer Group to Cover Its Excessive Sweat Medication; Shares Up 6%

MT Newswires Live

2024/11/14

Botanix Pharmaceuticals (ASX:BOT) said US payer organization Ascent Health will cover its Sofdra-branded sofpironium topical gel, 12.45%, for the treatment of primary axillary hyperhidrosis, or excessive sweating, according to a Thursday filing with the Australian bourse.

Ascent Health is the second largest payer in the US covering 65 million people, the filing said. The company is advancing reimbursement coverage deals with other payers.

Botanix Pharmaceuticals' shares rose past 6% in recent Thursday trade.

Price (AUD): $0.34, Change: $+0.02, Percent Change: +6.25%

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2483385898"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2483385898\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2483385898?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-14 09:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483385898","market":"sg","top_or_hot":-1,"title":"Botanix Pharmaceuticals Says US Payer Group to Cover Its Excessive Sweat Medication; Shares Up 6%","media":"MT Newswires Live","content":"<html><body><p> Botanix Pharmaceuticals (ASX:BOT) said US payer organization Ascent Health will cover its Sofdra-branded sofpironium topical gel, 12.45%, for the treatment of primary axillary hyperhidrosis, or excessive sweating, according to a Thursday filing with the Australian bourse.</p><p>Ascent Health is the second largest payer in the US covering 65 million people, the filing said. The company is advancing reimbursement coverage deals with other payers.</p><p>Botanix Pharmaceuticals' shares rose past 6% in recent Thursday trade.</p><p>Price (AUD): $0.34, Change: $+0.02, Percent Change: +6.25%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Botanix Pharmaceuticals Says US Payer Group to Cover Its Excessive Sweat Medication; Shares Up 6%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBotanix Pharmaceuticals Says US Payer Group to Cover Its Excessive Sweat Medication; Shares Up 6%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-11-14 09:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Botanix Pharmaceuticals (ASX:BOT) said US payer organization Ascent Health will cover its Sofdra-branded sofpironium topical gel, 12.45%, for the treatment of primary axillary hyperhidrosis, or excessive sweating, according to a Thursday filing with the Australian bourse.</p><p>Ascent Health is the second largest payer in the US covering 65 million people, the filing said. The company is advancing reimbursement coverage deals with other payers.</p><p>Botanix Pharmaceuticals' shares rose past 6% in recent Thursday trade.</p><p>Price (AUD): $0.34, Change: $+0.02, Percent Change: +6.25%</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7502","symbol_name":"大麻概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2483385898","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483385898","pubTimestamp":1731548434,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Botanix Pharmaceuticals  said US payer organization Ascent Health will cover its Sofdra-branded sofpironium topical gel, 12.45%, for the treatment of primary axillary hyperhidrosis, or excessive sweating, according to a Thursday filing with the Australian bourse.Ascent Health is the second largest payer in the US covering 65 million people, the filing said. The company is advancing reimbursement coverage deals with other payers.Botanix Pharmaceuticals' shares rose past 6% in recent Thursday trade.Price : $0.34, Change: $+0.02, Percent Change: +6.25%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7502":"大麻概念","LU0994945656.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC 2","LU2238339852.HKD":"NINETY ONE GSF GLOBAL ENVIRONMENT \"A\" (HKD) ACC","BK4125":"广播","BK7508":"医药生物股","LU0426412945.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) ACC","BOT.AU":"BOTANIX PHARMACEUTICALS LTD","LU0426417589.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC","BK7096":"制药","LU0345774631.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) INC","LU1043141123.HKD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (HKD) INC 2"},"translate_title":"Botanix Pharmaceuticals表示，美国支付集团将支付其过量的发汗药物；股价上涨6%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BOT.AU":0.9,"AUD":1},"content_text":"Botanix Pharmaceuticals (ASX:BOT) said US payer organization Ascent Health will cover its Sofdra-branded sofpironium topical gel, 12.45%, for the treatment of primary axillary hyperhidrosis, or excessive sweating, according to a Thursday filing with the Australian bourse.Ascent Health is the second largest payer in the US covering 65 million people, the filing said. The company is advancing reimbursement coverage deals with other payers.Botanix Pharmaceuticals' shares rose past 6% in recent Thursday trade.Price (AUD): $0.34, Change: $+0.02, Percent Change: +6.25%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}